Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Heterogeneity in allospecific T cell function in transplant-tolerant hosts determines susceptibility to rejection following infection
Christine M. McIntosh, … , Anita S. Chong, Maria-Luisa Alegre
Christine M. McIntosh, … , Anita S. Chong, Maria-Luisa Alegre
Published September 7, 2023
Citation Information: J Clin Invest. 2023;133(21):e168465. https://doi.org/10.1172/JCI168465.
View: Text | PDF
Research Article Article has an altmetric score of 15

Heterogeneity in allospecific T cell function in transplant-tolerant hosts determines susceptibility to rejection following infection

  • Text
  • PDF
Abstract

Even when successfully induced, immunological tolerance to solid organs remains vulnerable to inflammatory insults, which can trigger rejection. In a mouse model of cardiac allograft tolerance in which infection with Listeria monocytogenes (Lm) precipitates rejection of previously accepted grafts, we showed that recipient CD4+ TCR75 cells reactive to a donor MHC class I–derived peptide become hypofunctional if the allograft is accepted for more than 3 weeks. Paradoxically, infection-induced transplant rejection was not associated with transcriptional or functional reinvigoration of TCR75 cells. We hypothesized that there is heterogeneity in the level of dysfunction of different allospecific T cells, depending on duration of their cognate antigen expression. Unlike CD4+ TCR75 cells, CD4+ TEa cells specific for a peptide derived from donor MHC class II, an alloantigen whose expression declines after transplantation but remains inducible in settings of inflammation, retained function in tolerant mice and expanded during Lm-induced rejection. Repeated injections of alloantigens drove hypofunction in TEa cells and rendered grafts resistant to Lm-dependent rejection. Our results uncover a functional heterogeneity in allospecific T cells of distinct specificities after tolerance induction and reveal a strategy to defunctionalize a greater repertoire of allospecific T cells, thereby mitigating a critical vulnerability of tolerance.

Authors

Christine M. McIntosh, Jennifer B. Allocco, Peter Wang, Michelle L. McKeague, Alexandra Cassano, Ying Wang, Stephen Z. Xie, Grace Hynes, Ricardo Mora-Cartín, Domenic Abbondanza, Luqiu Chen, Husain Sattar, Dengping Yin, Zheng J. Zhang, Anita S. Chong, Maria-Luisa Alegre

×

Figure 6

Lm infection in tolerant hosts induces upregulation of MHCII on donor endothelium and results in expansion of cytokine-producing TEa cells.

Options: View larger image (or click on image) Download as PowerPoint
Lm infection in tolerant hosts induces upregulation of MHCII on donor en...
(A) Experimental design for D–E. TCR75 or TEa cells were adoptively transferred into congenic B6 recipients prior to transplantation with a B/c heart allograft and treatment with CoB to induce tolerance in all hosts. After 35+ days, a subset of mice were infected with Lm. Four to 8 days after infection, heart grafts were palpated and CD45.1+ T cells were recovered, counted, and analyzed by flow cytometry. (B) Total CD4+ T cells recovered from transplanted hearts at days 39 to 43 after transplantation. Tol (n = 9); Tol+Lm (n = 9). (C) Heart graft palpation score days 39 to 43. Hearts were scored, with a perfect score as 0 and a rejected heart as 4, on the following criteria: presence of heartbeat (absent = 1 point), graft size (enlarged =1 point), heartbeat speed (slow = 1 point), strength of heartbeat (weak = 1 point). No cells (n = 9), TCR75 (n = 7), TEa (n = 10), TCR-Tg (either TCR75 or TEa) +Lm (n = 15). (D) Total CD45.1+ T cells recovered from spleen and lymph nodes at days 39–43 after transplantation. TCR75 (n = 12), TCR75+Lm (n = 13), TEa (n = 20), TEa+Lm (n = 20). (E) The total number of CD45.1+ TEa T cells recovered by FACS was multiplied to the percentage of cells producing cytokines upon restimulation with anti-CD3/CD28 in vitro in the presence of brefeldin A. Values represent the number of cytokine-producing CD45.1+ TEa T cells per mouse. Tol (n = 9), Tol+Lm (n = 6). All data points represent a sample pooled from 1–2 mice, with lines indicating mean ± SEM. Data were analyzed by 2-tailed unpaired t test (B, D, and E comparing ± Lm for each TCR-Tg group) or 1-way ANOVA with Bonferroni’s correction for multiple pairwise comparisons (C). *P < 0.05, ***P < 0.001, ****P < 0.0001

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Posted by 14 X users
7 readers on Mendeley
See more details